IL10 and congenital rubella syndrome: These findings revealed that ZGGS15 does not induce the release of cytokines, such as IFN-γ, IL-2, IL-6, IL-10, and TNF-α from human immune cells, therefore mitigating any potential adverse effects of CRS.